AVALO THERAPEUTICS INC

Ticker: AVTX CUSIP: 05338F306 Class: COM NEW

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 166,152 Value ($000) $3,018 Avg Close $16.88 Range $12.41 - $20.72

Q3 2025

Shares 104,189 Value ($000) $1,325 Avg Close $8.60 Range $4.61 - $14.07

Q2 2025

Shares 110,460 Value ($000) $552 Avg Close $4.67 Range $3.39 - $8.37

Q1 2025

Shares 107,812 Value ($000) $864 Avg Close $7.58 Range $5.99 - $11.23

Q4 2024

Shares 104,853 Value ($000) $779 Avg Close $10.69 Range $7.34 - $16.00

Q3 2024

Shares 10,111 Value ($000) $96 Avg Close $10.31 Range $6.84 - $13.30

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	166,152	$3,018	$16.88	$12.41 - $20.72
Q3 2025	104,189	$1,325	$8.60	$4.61 - $14.07
Q2 2025	110,460	$552	$4.67	$3.39 - $8.37
Q1 2025	107,812	$864	$7.58	$5.99 - $11.23
Q4 2024	104,853	$779	$10.69	$7.34 - $16.00
Q3 2024	10,111	$96	$10.31	$6.84 - $13.30